Follow
Maria Secrier
Maria Secrier
Lecturer in Computational Biology, UCL Genetics Institute, University College London
Verified email at ucl.ac.uk
Title
Cited by
Cited by
Year
Using graph theory to analyze biological networks
GA Pavlopoulos, M Secrier, CN Moschopoulos, TG Soldatos, S Kossida, ...
BioData mining 4, 1-27, 2011
8512011
Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis
JMJ Weaver, CS Ross-Innes, N Shannon, AG Lynch, T Forshew, ...
Nature genetics 46 (8), 837-843, 2014
3712014
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance
M Secrier, X Li, N De Silva, MD Eldridge, G Contino, J Bornschein, ...
Nature genetics 48 (10), 1131-1141, 2016
3512016
Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics
X Li, HE Francies, M Secrier, J Perner, A Miremadi, N Galeano-Dalmau, ...
Nature communications 9 (1), 2983, 2018
2642018
TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A
AL Brown, OG Wilkins, MJ Keuss, SE Hill, M Zanovello, WC Lee, ...
Nature 603 (7899), 131-137, 2022
1922022
Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia
M Prudencio, J Humphrey, S Pickles, AL Brown, SE Hill, JM Kachergus, ...
The Journal of clinical investigation 130 (11), 2020
1192020
Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma
F Noble, MA Lloyd, R Turkington, E Griffiths, M O'Donovan, JR O'Neill, ...
Journal of British Surgery 104 (13), 1816-1828, 2017
1052017
Identification of prognostic phenotypes of esophageal adenocarcinoma in 2 independent cohorts
T Sawas, S Killcoyne, PG Iyer, KK Wang, TC Smyrk, JB Kisiel, Y Qin, ...
Gastroenterology 155 (6), 1720-1728. e4, 2018
812018
Molecular landscape of esophageal cancer: implications for early detection and personalized therapy
FR Talukdar, M di Pietro, M Secrier, M Moehler, K Goepfert, SSC Lima, ...
Annals of the New York Academy of Sciences 1434 (1), 342-359, 2018
742018
Identification of subtypes of Barrett’s esophagus and esophageal adenocarcinoma based on DNA methylation profiles and integration of transcriptome and genome data
SG Jammula, AC Katz-Summercorn, X Li, C Linossi, E Smyth, S Killcoyne, ...
Gastroenterology 158 (6), 1682-1697. e1, 2020
732020
Visualizing time-related data in biology, a review
M Secrier, R Schneider
Briefings in bioinformatics 15 (5), 771-782, 2014
592014
The ABC of reverse engineering biological signalling systems
M Secrier, T Toni, MPH Stumpf
Molecular BioSystems 5 (12), 1925-1935, 2009
582009
Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma
A Noorani, X Li, M Goddard, J Crawte, LB Alexandrov, M Secrier, ...
Nature genetics 52 (1), 74-83, 2020
572020
Arena3D: visualizing time-driven phenotypic differences in biological systems
M Secrier, GA Pavlopoulos, J Aerts, R Schneider
BMC bioinformatics 13, 1-11, 2012
572012
Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium. Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with …
M Secrier, X Li, N de Silva, MD Eldridge, G Contino, J Bornschein, ...
Nat Genet 48 (10), 1131-1141, 2016
342016
Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinoma
N De Silva, L Schulz, A Paterson, W Qain, M Secrier, E Godfrey, H Cheow, ...
British journal of cancer 113 (9), 1305-1312, 2015
312015
A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre-and post-chemotherapy
A Noorani, J Bornschein, AG Lynch, M Secrier, A Achilleos, M Eldridge, ...
Genome research 27 (6), 902-912, 2017
272017
Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1
E Garcia, A Hayden, C Birts, E Britton, A Cowie, K Pickard, M Mellone, ...
Scientific reports 6 (1), 32417, 2016
272016
Cell environment shapes TDP-43 function with implications in neuronal and muscle disease
U Šušnjar, N Škrabar, AL Brown, Y Abbassi, H Phatnani, A Cortese, ...
Communications biology 5 (1), 314, 2022
262022
Common ALS/FTD risk variants in UNC13A exacerbate its cryptic splicing and loss upon TDP-43 mislocalization
AL Brown, OG Wilkins, MJ Keuss, SE Hill, M Zanovello, WC Lee, FCY Lee, ...
Biorxiv, 2021.04. 02.438170, 2021
262021
The system can't perform the operation now. Try again later.
Articles 1–20